With the Affordable Care Act poised to become repealed, or at least changed, researchers sought to understand the health and healthcare utilization of people at risk to lose their insurance.
With President Donald J. Trump in the White House and Republicans controlling both the House of Representatives and the Senate, the Affordable Care Act (ACA) is almost guaranteed to be repealed, or at least modified. As a result, there should be a better understanding of health and healthcare use by individuals who are at risk of losing their insurance with a repeal of the ACA, wrote authors of a letter in JAMA Internal Medicine.
“Our analysis highlights the socioeconomic vulnerability and rates of chronic diseases and healthcare utilization of individuals at risk of lose health insurance if the ACA is modified or repealed such that premium tax credits are eliminated and Medicaid expansion is rolled back,” the authors wrote.
The researchers used the Integrated Health Interview Series of the 2015 National Health Interview Survey and identified 3 groups of adults under the age of 65 who were at risk of losing their health insurance through changes to or a repeal of the ACA.
The groups were as follows:
These adults were all more likely to be minorities, poor, and unemployed compared with adults with employer-sponsored insurance. Adults who have employer-sponsored insurance are unlikely to be affected by changes in subsidies or to Medicaid.
Adults in the groups more likely to lose their insurance had higher rates of self-reported poor health and were more likely to have visited the emergency department, been hospitalized, have a high number of physician officer visits, and have certain chronic diseases.
“The serious consequences for those at risk to lose coverage if premium tax credits and Medicaid expansion are rolled back are striking,” the authors concluded. “These consequences point to the challenges Congress should address before enacting new health care legislation.”
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More